Target intelligence / Profile preview

Taste receptor type 2 member 7 (TAS2R7)

Target
TAS2R7
Molecular classification
G protein-coupled receptor (GPCR), Receptor (specifically: bitter taste receptor)
01

Overview

Taste receptor type 2 member 7 is a G protein-coupled receptor encoded by the *TAS2R7* gene. It is specifically expressed in taste receptor cells of the tongue and palate epithelia, where it mediates the detection and signal transduction of bitter tastants. TAS2R7 belongs to the large family of bitter taste receptors (TAS2Rs), which are characterized by diverse agonist profiles ranging from narrowly to broadly tuned sensitivity to bitter chemicals. The canonical pathway involves activation through gustducin and downstream effectors like PLCβ2 and TRPM5, resulting in taste signal transmission to the brain. In addition to its classical role in oral bitter sensing, TAS2R7 and other members of the TAS2R family are expressed in extraoral tissues, potentially contributing to non-gustatory functions such as immune and metabolic regulation. No specific clinical drugs or disease associations are established for TAS2R7, though its ability to bind multiple bitter compounds makes it relevant for flavor and nutrition studies[1][2][3][4].

Other names
TAS2R7T2R7Taste receptor, family B, member 4TRB4
02

Mechanism of action

The receptor binds bitter molecules (agonists), activates G protein gustducin, triggering downstream signal transduction including PLCβ2 activation, production of IP₃, calcium release, TRPM5 channel activation, and action potential generation in taste receptor cells. Antagonists: molecules that block TAS2R7-mediated bitter sensing

03

Biological functions

Signal transductionSensory perception of bitter tasteBitter tastant detectionTaste signalling via gustducin (G protein), PLCβ2, TRPM5 pathwaysAdditional extraoral physiological roles including modulation of innate immunity, respiratory function, digestive system, and metabolism
04

Disease associations

Other (no direct, established role in major disease categories such as cancer, inflammation, etc.; possible associations in taste disorders and involvement in extraoral physiology remain under investigation)
05

Interacting drugs

Bitter compounds (agonists): various natural and synthetic molecules classified as "bitter salts"; specific interacting drugs are not well-established in clinical pharmacology

1 more in the full profile.

Beyond the preview

Go deeper on Taste receptor type 2 member 7 (TAS2R7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Taste receptor type 2 member 7 (TAS2R7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call